Exact Sciences
EXAS
#1154
Rank
โ‚ฌ17.85 B
Marketcap
93,54ย โ‚ฌ
Share price
0.00%
Change (1 day)
101.68%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -โ‚ฌ0.17 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚ฌ3.24 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚ฌ0.17 Billion-82.05%
2024 -โ‚ฌ0.91 Billion435.05%
2023 -โ‚ฌ0.17 Billion-69.18%
2022 -โ‚ฌ0.55 Billion-25.77%
2021 -โ‚ฌ0.74 Billion1.68%
2020 -โ‚ฌ0.73 Billion271.17%
2019 -โ‚ฌ0.2 Billion58.99%
2018 -โ‚ฌ0.13 Billion20.89%
2017 -โ‚ฌ0.11 Billion-30.95%
2016 -โ‚ฌ0.15 Billion5.09%
2015 -โ‚ฌ0.15 Billion57.24%
2014 -โ‚ฌ89.38 Million116.53%
2013 -โ‚ฌ41.28 Million
2011 -โ‚ฌ25.7 Million143.73%
2010 -โ‚ฌ10.55 Million27.85%
2009 -โ‚ฌ8.25 Million0.27%
2008 -โ‚ฌ8.23 Million-20.95%
2007 -โ‚ฌ10.41 Million-13.53%
2006 -โ‚ฌ12.04 Million-10.07%
2005 -โ‚ฌ13.39 Million-21.81%
2004 -โ‚ฌ17.12 Million-33.44%
2003 -โ‚ฌ25.72 Million-6.51%
2002 -โ‚ฌ27.51 Million17.95%
2001 -โ‚ฌ23.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚ฌ6.38 B-4,029.45%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
โ‚ฌ0.10 B-163.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚ฌ58.74 M-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚ฌ0.35 Billion 111.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚ฌ31.18 Million-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA